Is CCCC a good stock to buy? C4 Therapeutics, Inc. (NASDAQ: CCCC) was in 20 hedge funds' portfolios at the end of March. The all time high for this statistic is 22. CCCC investors should pay attention ...

C4 Therapeutics, Inc. (CCCC) has been on a downward spiral lately with significant selling pressure. After declining 26.2% over the past four weeks, the stock looks well positioned for a trend ...

CCCC Lisbon 2025 shifted from spectacle to production, with creators using AI, refining influence, and building real Web3 strategy.

The price trend for C4 Therapeutics, Inc. (CCCC) has been bearish lately and the stock has lost 7% over the past week. However, the formation of a hammer chart pattern in its last trading session ...

As of September 13, 2025, the average one-year price target for C4 Therapeutics is $14.79/share. The forecasts range from a low of $3.03 to a high of $52.50. The average price target represents an ...

Central Carolina Community College celebrated its 2024-2025 student-athletes at the annual Athletics Banquet Awards Ceremony on Wednesday, April 16, at the Dennis A. Wicker Civic & Conference Center ...

MANILA, Philippines — State-owned China Communications Construction Co. Ltd. (CCCC) has again expressed its interest in developing the Sangley Point International Airport (SPIA) project in Cavite ...

Kuwait will sign a contract next week with China Communications Construction Company (CCCC) to complete the Mubarak Al-Kabeer ...

A downtrend has been apparent in C4 Therapeutics, Inc. (CCCC) lately with too much selling pressure. The stock has declined 23.1% over the past four weeks. However, given the fact that it is now in ...